Titre:
  • PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer.
Auteur:Majewski, Ian IJ; Nuciforo, Paolo; Mittempergher, Lorenza; Bosma, Astrid AJ; Eidtmann, Holger; Holmes, Eileen; Sotiriou, Christos; Fumagalli, Debora; Jimenez, Jose; Aura, Claudia; Prudkin, Ljudmila; Díaz-Delgado, Maria Carmen; de la Peña, Lorena; Loi, Sherene; Ellis, Catherine; Schultz, Nikolaus; Azambuja, Evandro; Harbeck, Nadia; Piccart-Gebhart, Martine; Bernards, René; Baselga, José
Informations sur la publication:Journal of clinical oncology
Statut de publication:Publié, 2015-01
Sujet CREF:Cancérologie
Médecine pathologie humaine
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2014.55.2158
info:pii/JCO.2014.55.2158
info:scp/84927620697
info:pmid/25559818